Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs T-Mobile Us Inc (TMUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs T-Mobile Us Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while T-Mobile Us Inc trades at $159.25 (market cap $169.26B). The key difference: T-Mobile Us Inc is far larger — about 5.5× GE HealthCare Technologies Inc. Common Stock's market cap, and T-Mobile Us Inc pays the higher dividend (2.97%). Which is the better fit depends on your goals.
| GEHC | TMUS | |
|---|---|---|
Market Cap | $30.93B | $169.26B |
Volume | 5,033,451 | 7,268,670 |
Sector | Health | Media |
52-Week High | $88.16 | $230.06 |
52-Week Low | $59.48 | $148.58 |
Enterprise Value | $39.39B | $285.87B |
Dividend Yield | 0.23% | 2.97% |
Typical Hold Time | — | 84 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
T-Mobile US (TMUS) trades at $153.73, up 1.22% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with $88.31B revenue in 2025, 11.45% net margin, and consistent earnings beats in recent quarters. Recent developments include a 15% dividend increase and participation in a satellite connectivity joint venture with major carriers. Analyst sentiment remains overwhelmingly positive with 81% buy ratings and a $221.75 consensus price target representing significant upside potential.
TMUS presents a compelling growth story with improving profitability and strategic initiatives, though investors face risks from $84.6B debt load and competitive pressures. The stock's current valuation at 16.08 P/E appears reasonable given earnings growth trajectory. Technical resistance at $154-158 levels may challenge near-term momentum, but strong institutional support and dividend growth support long-term bullish case.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About T-Mobile Us Inc
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, creating T-Mobile Us. Following the merger, the firm provided nationwide service in major markets but spottier coverage elsewhere. T-Mobile spent aggressively on low-frequency spectrum, well suited to broad coverage, and has substantially expanded its geographic footprint. This expansion, coupled with aggressive marketing and innovative offerings, produced rapid customer growth. With the Sprint acquisition, the firm's scale now roughly matches its larger rivals: T-Mobile now serves 71 million postpaid and 21 million prepaid phone customers, equal to around 30% of the U.S. retail wireless market. In addition, the firm provides wholesale service to resellers.
Read more on TMUS →
